EVANS SYNDROME
Clinical trials for EVANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new EVANS SYNDROME trials appear
Sign up with your email to follow new studies for EVANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cell therapy tested for stubborn autoimmune blood disorders
Disease control Recruiting nowThis early-phase study is testing a new 'universal' CAR-T cell therapy called RD06-05 in adults with severe autoimmune blood diseases that haven't responded well to standard treatments. The main goal is to check the safety of two different doses and see how well the therapy works…
Matched conditions: EVANS SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New drug trial targets stubborn autoimmune blood diseases
Disease control Recruiting nowThis early-stage study is testing an experimental drug called CM336 in adults whose autoimmune blood disorders have not responded to other treatments. The main goals are to see if the drug is safe and if it can help improve patients' blood cell counts. Researchers will monitor fo…
Matched conditions: EVANS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC